Quercetin synergizes with 2-methoxyestradiol inhibiting cell growth and inducing apoptosis in human prostate cancer cells

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 357-363

  Wang, Guodong ^a   Song, Liming ^a   Wang, Huiping ^b   Xing, Nianzeng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

2 methoxyestradiol; Apoptosis; Combination agents; Prostate cancer; Quercetin

Indexed keywords

2 METHOXYESTRADIOL; ANDROGEN; PROTEIN BAX; PROTEIN BCL 2; QUERCETIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL LEVEL; CELL POPULATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DRUG POTENTIATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; ESTRADIOL; HUMANS; MALE; PROSTATIC NEOPLASMS; QUERCETIN; TUBULIN MODULATORS;

EID: 84878182888     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2469     Document Type: Article

References (26)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Tannock IF, de Wit R, Berry WR, et al: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351: 1502-1512, 2004. (Pubitemid 39315317)
3. Berthold DR, Pond GR, Soban F, de Wit R, Eisenberger M and Tannock IF: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 26: 242-245, 2008.
4. Wenner CA, Martzen MR, Lu H, Verneris MR, Wang H and Slaton JW: Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer. Int J Oncol 40: 905-913, 2012.
5. Kim MK, Park KS, Lee C, Park HR, Choo H and Chong Y: Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety. J Med Chem 53: 8597-8607, 2010.
6. Yuan ZP, Chen LJ, Fan LY, et al: Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 12: 3193-3199, 2006.
7. Kumar R, Verma V, Jain A, Jain RK, Maikhuri JP and Gupta G: Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J Nutr Biochem 22: 723-731, 2011.
8. Hsieh TC and Wu JM: Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin. Anticancer Res 29: 4025-4032, 2009.
9. Ma Z, Hung Nguyen T, Hoa Huynh T, Tien Do P and Huynh H: Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation. J Endocrinol 181: 493-507, 2004. (Pubitemid 38868199)
10. Kumar AP, Garcia GE and Slaga TJ: 2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells. Mol Carcinog 31: 111-124, 2001. (Pubitemid 32744531)
11. Fotsis T, Zhang Y, Pepper MS, et al: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237-239, 1994. (Pubitemid 24108838)
12. Sweeney C, Liu G, Yiannoutsos C, et al: A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin Cancer Res 11: 6625-6633, 2005. (Pubitemid 41339003)
13. Ghosh R, Ganapathy M, Alworth WL, Chan DC and Kumar AP: Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol 113: 25-35, 2009.
14. Ram CV: Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies. J Clin Hypertens (Greenwich) 6: 569-577, 2004.
15. Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55, 1984.
16. Smith DC, Tangen CM, Van Veldhuizen PJ Jr, et al: Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032. Urology 77: 1172-1176, 2011.
17. Nair SK, Verma A, Thomas TJ, et al: Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine. Cancer Lett 250: 311-322, 2007. (Pubitemid 46541721)
18. Lee DH, Szczepanski M and Lee YJ: Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem Pharmacol 75: 2345-2355, 2008.
19. Chang YF, Hsu YC, Hung HF, et al: Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells. Nutr Cancer 61: 735-745, 2009.
20. Vijayababu MR, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas MM and Arunakaran J: Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 131: 765-771, 2005. (Pubitemid 41577954)
21. Shabbits JA, Hu Y and Mayer LD: Tumor chemosensitization strategies based on apoptosis manipulations. Mol Cancer Ther 2: 805-813, 2003.
22. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999. (Pubitemid 29407357)
23. Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101, 2011.
24. Zhou C, Li X, Du W, et al: Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy 56: 393-402, 2010.
25. Xu G, Gong Z, Yu W, Gao L, He S and Qian Z: Increased expression ratio of Bcl-2/Bax is associated with crocin-mediated apoptosis in bovine aortic endothelial cells. Basic Clin Pharmacol Toxicol 100: 31-35, 2007. (Pubitemid 46051440)
26. Basu A and Haldar S: Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Lett 538: 41-47, 2003. (Pubitemid 36287422)